News Conference News ACC 2026 PCSK9 Inhibitor Very Effective in High-risk Patients Without ASCVD: VESALIUS-CV By Michael O'Riordan March 29, 2026
News Conference News ACC 2026 Barbershop Effort Falls Short for Hypertension Prevention in Black Men By Todd Neale March 29, 2026
News Conference News ACC 2026 Very Low LDL Levels Best in Secondary Prevention: Ez-PAVE By Yael L. Maxwell March 28, 2026
News Conference News ACC 2026 KARDINAL: Monthly Tonlamarsen May Not Enhance BP Lowering in Resistant Hypertension By Caitlin E. Cox March 28, 2026
News Conference News ACC 2026 HI-PEITHO: Catheter-Directed Therapy Bests Anticoagulation in Intermediate-Risk PE By L.A. McKeown March 28, 2026
News Conference News ACC 2026 CHAMPION-AF: A Win for Watchman FLX, but With Caveats By Todd Neale March 28, 2026
News Conference News ACC 2026 Mechanical Circulatory Support Doesn’t Reduce Infarct Size in STEMI By Michael O'Riordan March 28, 2026
News Conference News CRT 2026 TAVR-MET: Early Signs Point to Less Postprocedural Valve Dysfunction With Tirzepatide By L.A. McKeown March 19, 2026
News Conference News Now Published: LAAO Doesn’t Match Medical Therapy for High-risk AF Patients in CLOSURE-AF By Caitlin E. Cox March 18, 2026